| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 68.5448 | 69 |
| GSM780708 | Untreated after 4 days (C2_1) | 70.4975 | 69 |
| GSM780709 | Untreated after 4 days (C3_1) | 55.8133 | 61 |
| GSM780719 | Untreated after 4 days (C1_2) | 54.9382 | 59 |
| GSM780720 | Untreated after 4 days (C2_2) | 84.8065 | 73 |
| GSM780721 | Untreated after 4 days (C3_2) | 59.9055 | 64 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 70.9664 | 69 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 69.7402 | 69 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 71.1861 | 69 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 65.5591 | 67 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 63.0713 | 66 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 64.9814 | 67 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 66.3415 | 68 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 82.416 | 72 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 60.3934 | 65 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 62.6574 | 66 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 66.2574 | 68 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 66.411 | 68 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 66.1486 | 68 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 71.8207 | 70 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 95.1015 | 74 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 80.869 | 72 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 83.0091 | 72 |